Antifragile Thinking

Author: The Investor's Mind, Framing Business Uncertainty | |

[Antifragile Thinking @unseenvalue]

When everyone is pumping the CDMO narrative, don't ask who is a CDMO. Ask who would still be a CDMO if the word disappeared from the presentation or annual report ...

[Antifragile Thinking @unseenvalue]

One for the notebook.

#Heuristics

[Antifragile Thinking @unseenvalue]

@VRtrendfollower 🙏

[Antifragile Thinking @unseenvalue]

Best place to enjoy vegetarian food in Surat? Thanks.

[Antifragile Thinking @unseenvalue]

$SDGR surges another 15% today. US biotech and cybersecurity space have been good at an aggregate level in 2026.

[Antifragile Thinking @unseenvalue]

The Machine Behind the Molecules

https://t.co/BQOPs4Wfpz

$SDGR | Schrodinger

[Antifragile Thinking @unseenvalue]

The chart is the receipt. The thesis is the meal.

$SDGR

[Antifragile Thinking @unseenvalue]

Skip the buyback theatre. Sales grow 6% a year; profits shrink 11%. That’s not a growth story. It’s a slow leak. Call it what it is.

[Antifragile Thinking @unseenvalue]

The best of Syngene is still ahead, but take it one quarter at a time. Do not confuse hope with proof.

Everything they said on today’s Q2 FY27 earnings call sounded honest and grounded, without the usual corporate spin. That is brutal honesty, and I appreciate it.

May they have the strength to keep going, and a fair share of luck too.

https://t.co/XiD92XdxLr

[Antifragile Thinking @unseenvalue]

But here’s what I’d tell my younger self: the scraped knee was the lesson, not the strategy.

For every trader who lost 90% and came back, many never did. You don’t hear from them. That is the idea behind “Silent Evidence”, the last heuristic chapter of The Investor’s Mind: we overlearn from survivors and underlearn from those who disappeared.

Tinker, experiment, make mistakes, but keep them small enough to survive. Fall early. Fall small. Learn fast. Ghutne chilne do, gardan mat katne do.

[Antifragile Thinking @unseenvalue]

I lost > 90% capital in my first year (1995). There was no Twitter or mentor to teach me. Khud sekha. Gire. Ghutne chil gaye….sekh gaye!

[UK in India🇬🇧🇮🇳 @UKinIndia]

Diwali at 10 Downing Street in London 🪔 🪔 🪔

Prime Minister Andy Burnham and his wife Marie-France van Heel lit diyas and joined the Indian diaspora to celebrate the spirit of Diwali.

[Antifragile Thinking @unseenvalue]

Concord Bio, Syngene and Piramal Pharma all reported better numbers. But a good quarter is not proof of a good system. The more interesting question is what the numbers still don’t reveal.

New post 👇

https://t.co/OqAnEce9IH

[Antifragile Thinking @unseenvalue]

The art is not knowing when to sell. It is knowing when to own less.

[Antifragile Thinking @unseenvalue]

@Vitawealth1 Read their analysis, thinking. Then, compare with your own notes. See if there are blind spots. Price targets are always for fragilistas.

[Antifragile Thinking @unseenvalue]

IF 700: I'd buy
ELSE IF: 600 - I'd buy more
END

Buridan's Donkey lens

Buridan's Donkey is a special lens. Not a tip/advice for mass consumption. Never clone. Invested in सोना since Sep 2025

[Nimesh Shah @nimeshscnbc]

Bernstein on Sona BLW
OW, TP Rs 850
Q2 Revenue growth (+35% YoY) reflects several levers coming through together: traction motors gaining share, strong recovery in differential assemblies, & suspension motors scaling in China
Business enters H2 with a broader base of growth & further programs to ramp
While declining percentage margins will understandably attract attention, don’t think earnings case require a return to historical peaks while revenue opportunity continues to expand
Management has, however, retained its 23-25% EBITDA margin framework

CITI on Sona BLW
Buy, TP Raised to Rs 960
Strong beat in 2QFY27 results, driven by a robust revenue growth.
Suspension motors, traction motors and differential assemblies segments saw strong trends.
Demand outlook remains positive, with tailwinds for global EVs as well as domestic E2W sectors .
New products are likely to result in Sona’s growth being higher than underlying industry’s.
Orderbook trends improved with (Rs251bn now vs Rs240bn as of 1QFY27 end).
That said, margins are likely to remain under pressure, given 1) severe material cost inflation, 2) increase in freight rates, & 3) mix shift towards 2W traction motors (low margin).

Kotak Inst Eqt on Sona BLW
Sell, TP Rs 700
2QFY27 EBITDA came in 9.5% above estimates due to a better-than-expected revenue print
Expect revenue growth to accelerate, owing to
(1) recovery in differential assembly business,
(2) strong momentum in traction motors and railway segments
(3) incremental opportunity in differential gears.
Beyond current products, expect Physical AI & BEV traction motor opportunity to drive medium-term growth prospects
Valuation remains expensive, which drives SELL

JPM on Sona BLW
UW, TP Rs 600
2QFY27 a beat vs expectations.
Revenue of Rs 15.5bn (+35% YoY) was 7% above JPMe, while EBITDA of Rs 3.6bn (+23% YoY) was +5% vs JPMe
EV revenues grew 129% YoY due to a combination of:
1) normalisation of differential assembly revenues in North America,
2) traction motor growth in Indian 2W/3W EVs, and
3) suspension motors ramp-up in China
Raising FY27-29 revenue and EBITDA forecast by 9-13% and 5-10%, respectively
This should drive an EPS CAGR (FY26-29) of 23%, but stock is already trading at 47xFY28 P/E
@CNBCTV18News @sudarshankr

[Antifragile Thinking @unseenvalue]

@Pjain1981 UK mein dhoop mushkil se milti hai ... isliye yahan “धूप में चलना” नहीं, “धूप में निकलना” achievement hai 😄

[Antifragile Thinking @unseenvalue]

Always .... if your horizon is extremely short, start with the price, not the story.

Unimech Aerospace
Syngene
Piramal Pharma

I have no view on the stock per se. Your risk capital is yours. Your judgement is yours. So are the consequences!

[Antifragile Thinking @unseenvalue]

If a framework cannot survive contact with a different industry, it is not a framework. It is a narrative wearing a framework’s clothes.

Can the same framework be applied to Divis, Laurus, Anthem, Sai Life, Shilpa Medicare, Aether Industries, Unimech, Sansera and Sona Comstar?

A static snapshot tells you what the business is. Rate of change tells you what it is becoming.

That is where the real test begins. Old engines must be replaced. Diversification must show up in the numbers. And what management says today must survive contact with FY28.

If the framework cannot travel, it is not a framework.

Acutaas 👇

https://t.co/0AA9XMsgR1

[Antifragile Thinking @unseenvalue]

@govindgoyal83 @kiranshaw This is new Syngene indeed, as explained on 10th Oct

https://t.co/3fzrjvLELc

[Antifragile Thinking @unseenvalue]

Joined Syngene’s Q2 call at 3:30 am UK time and had a meaningful exchange with Siddharth Mittal on how the new team plans to keep programmes from discovery through to commercial supply.
Worth a listen.
Thank you, @kiranshaw, for leading from the front.

(Disclosure: Family owns shares. Not investment advice.)

[Antifragile Thinking @unseenvalue]

@Drdivyanshu88 https://t.co/jHCPWIf9hg

[Antifragile Thinking @unseenvalue]

Acutaas Chemicals trades at ~19x sales.

You're not buying today's business. You're buying its ability to keep improving faster than the valuation becomes demanding.

"3 FY28 paths" and the hurdle every quarter must clear is here:

https://t.co/jCDOwctbJ9

Not investment advice!

[Antifragile Thinking @unseenvalue]

@hologramtruth 👀

[Antifragile Thinking @unseenvalue]

"₹2000 crores CDMO by FY30" – CMD, Acutaas Chemicals, Q2 FY27 earnings call

[Antifragile Thinking @unseenvalue]

@oldschoolinvest Laurus 2023 🙈

[Antifragile Thinking @unseenvalue]

@DipenVora0112 @AnkushG31615946 Santaap is always a function of average allocation price and % allocation. For someone entering in 2016 when the price was less than 90, even 900 is not true "santaap" – yes, one can say there were better places at 3000. Add dividends, and even 800 is fine for them ;)